Bausch Health Companies Inc. (TSE:BHC - Get Free Report)'s stock price rose 1.4% on Monday . The company traded as high as C$6.64 and last traded at C$6.53. Approximately 370,325 shares were traded during trading, an increase of 7% from the average daily volume of 346,977 shares. The stock had previously closed at C$6.44.
Bausch Health Companies Stock Performance
The stock has a market cap of C$1.59 billion, a price-to-earnings ratio of -8.96, a PEG ratio of 0.21 and a beta of 0.77. The stock's 50 day moving average is C$7.45 and its two-hundred day moving average is C$9.66. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94.
About Bausch Health Companies
(
Get Free Report)
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Recommended Stories
Before you consider Bausch Health Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bausch Health Companies wasn't on the list.
While Bausch Health Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
